Business

Cellebrite Announces Participation in the 27th Annual Needham & Company Growth Conference

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative

Cellebrite Di Ltd.January 8, 20254
Cellebrite Announces Participation in the 27th Annual Needham & Company Growth Conference

About this update from Cellebrite Di Ltd.

TYSONS CORNER, Va. and PETAH TIKVA, Israel , Jan. 08, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the Company will participate in the upcoming Needham & Company Growth Conference . Relevant details include: Date: January 14, 2025 Conference: Needham & Company 27th Annual Growth Conference Presentation Time: 8:45 a.m. ET Format Fireside Chat Event URL: https://investors.cellebrite.com/events/event-details/needham-co-27th-annual-growth-conference Cellebrite Executives: Dana Gerner , chief financial officer Andrew Kramer , vice president, investor relations About Cellebrite Cellebrite’s (Nasdaq: CLBT) mission is to enable its customers to protect and save lives, accelerate justice and preserve privacy in communities around the world. We are a global leader in Digital Investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Investigation platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more, visit us at www.cellebrite.com , https://investors.cellebrite.com , or follow us on Twitter at @Cellebrite. Investor Relations Andrew Kramer Vice President, Investor Relations [email protected] +1 973.206.7760 Media Victor Cooper Sr. Director of Corporate Communications + Content Operations [email protected] +1 404.804.5910 Source: Cellebrite DI Ltd

View stock analysis, news, and events for Cellebrite Di Ltd.

More from Cellebrite Di Ltd.

All Cellebrite Di Ltd. news →